New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

Mar 18, 2022
Funding from the Government to the support provided to Horizon Europe launched in November 2021 will be extended, it was announced this week. This guarantee comes as efforts continue for the UK’s association to the large-scale research programme to be formalised. The funding will now be in place for awards expected to be signed by the end of December 2022.The UK and EU had agreed upon terms in the Trade and Cooperation Agreement last year that would ensure the UK’s association to the...
Read More
Mar 14, 2022
BIVDA Statement - BIVDA responds to the BEIS R&D partner organisation budget  For Immediate Release -  The Government’s commitment to increasing the R&D budget to £39.8 billion – the largest ever – is welcomed by BIVDA. As the UK’s most representative association for in vitro diagnostic (IVD) technology and innovation, we acknowledge that this investment will provide our industry with vital funds to be able to pioneer cutting-edge researc...
Read More
Mar 11, 2022
BIVDA enjoyed an excellent day in Parliament as dozens of university researchers exhibited posters encompassing their innovative research projects. BIVDA has long supported the annual competition with our CEO Doris-Ann Williams chairing the organising committee.Indeed, the organising team’s hard work paid off as esteemed politicians, such as Shadow Science, Research and Digital Minister Chi Onwurah MP and Chair of the APPG for Life Sciences Daniel Zeichner MP, turned up in great numbers to...
Read More
Mar 11, 2022
The Government have today announced a number of loan competitions worth up to £150 million to support research and development projects from the UK’s most innovative businesses. Funded by Innovate UK, the scheme aims to supports projects which are determined to have the greatest chance of bolstering future economic growth while concurrently tackling social challenges.The Government views this initiative as key to supporting the plans set out in the Innovation Strategy, which was rele...
Read More
Mar 11, 2022
Health and Social Care Secretary Sajid Javid attended the CEPI Global Pandemic Preparedness Summit 2022 this Tuesday 8 March where he made a speech on the UK’s readiness to react to public health threats as well as the required focus on vaccinations and diagnostics.CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations. It works to accelerate the development of vaccines against emerging infectious diseases and enable equitable acces...
Read More
Mar 04, 2022
This new campaign’s novel approach focuses on tackling the fear of cancer itself rather than specific symptoms to try to detect cancers early. Its key message, which will run across both traditional and social media, is: if you feel something is wrong, then get checked. The aim of this is to give patients peace of mind or, if something is indeed wrong, the best chance of successful treatment through an early diagnosis.NHS data has shown that anxiety about cancer is widespread and can have ...
Read More
Mar 04, 2022
The Government has stated that £200 million will be spent on making NHS data more readily available for research and increasing its security and accessibility. It is hoped that this will allow the NHS to deliver innovative new treatments faster and increase diversity in clinical trials to combat existing health inequalities.In a further boost to the life sciences sector, the remaining money will be used to create a £60 million Life Sciences Innovative Manufacturing Fund (LSIMF). The ...
Read More
Mar 02, 2022
RQM+, the world’s leading provider of regulatory, clinical and quality solutions to the MedTech industry, today announced the appointment of Margaret Keegan as CEO. Keegan succeeds co-founder Maria Fagan, who is retiring and will join the board of directors as vice chair.
Read More
Mar 02, 2022
BIVDA, the UK’s leading association for in vitro diagnostic (IVD) technology and innovation, welcomes the £200 million in funding announced by BEIS and DHSC to support critical health research into diagnostics and treatment through enhanced data access and digital clinical trial services. Following on from the Medicines and Diagnostics Manufacturing Transformation Fund, a new £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) will help to broaden the commercial-sca...
Read More
Mar 01, 2022
BIVDA welcomes today’s announcement by NHS chief executive Amanda Pritchard of a new campaign which encourages the public to get tested early if they fear they may have cancer.
Read More
Page 14 of 36 [14]

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858